*Corresponding author:
Georgios Z Papadakis MD, MPH, PhD, Computational Biomedicine Laboratory (CBML), Foundation for Research and Technology Hellas (FORTH), N. Plastira 100, Vassilika Vouton, GR-70013, Heraklion, Crete, GreeceReceived: December 05, 2018; Published: December 14, 2018
DOI: 10.26717/BJSTR.2018.12.002215
To view the Full Article Peer-reviewed Article PDF
Although the idea of personalization of patient care dates to the time of Hippocrates, recent advances in diagnostic medical imaging and molecular medicine are gradually transforming health care services, by offering information and diagnostic tools enabling individualized patient management. One of the most critical challenges in personalized medicine is to transform big, multi-modal data into decision support tools, capable to bridge the translational gap to the clinical setting. Deep Learning (DL) provides a new approach to derive high-accuracy, multi-modal predictive models, which will enable implementation of the personalized medicine vision soon.
Opinion| References|
International Association of Landscape Archaeology, Czech Glass Society, Czech Republic
Department of Chemistry, Semenov Institute of Chemical Physics, USSR Academy of Sciences, Moscow, Russia
Pharmaco-kinetics, dynamics and Drug Metabolism, Touro College of Pharmacy, USA
Professor of Nuclear Medicine, Faculty of Medicine and Surgery, University of Milan, Milan, Italy
Associate Professor at Department of Breast and Thyorid Surgey, Chongqing General Hospital, China